Tirzepatide 60mg Peptide

60mg Tirzepatide is a research grade pure peptide that is available as a lyophilized form and can be used in research and analyses. 60mg Tirzepatide is a dual-receptor acting peptide which acts through the GIP and GLP-1 receptors.
As a result, it offers scientists a dual receptor acting compound for studying the signaling pathway of incretins. The advantage of 60mg Tirzepatide over other presentations is in its increased quantity.

Tirzepatide 60mg – Dual Agonist Research Peptide

Tirzepatide represents a man-made peptide that works according to its unique dual-receptor system. In contrast to the GLP-1 receptor agonism, this peptide shows its receptor agonistic activity in relation to the glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor.
This specific feature has rendered Tirzepatide a valuable chemical in investigations related to incretin physiology, receptor specificity, and differences between single and multiple receptor agonists.
60 mg format is more convenient for large-scale studies.

Why Choose Tirzepatide 60mg?

This 60 mg vial is considered to be the largest quantity Tirzepatide preparation amongst the research scope. It may be appropriate for laboratories that need more substance for further analysis, re-running experiments or conducting studies where consistency of substance from one single batch is essential.
Compared to the smaller quantity 20 mg, 30 mg or 45 mg vials, this 60 mg formulation offers larger quantity of the substance without altering its molecular structure.
Scientists should choose the quantity of vials depending on the needs of the experiment.

Dual GIP and GLP-1 Receptor Activity

The scientific interest surrounding Tirzepatide is closely connected to its ability to interact with two incretin receptor systems.
The GIP receptor is associated with glucose-dependent insulinotropic polypeptide signalling and is widely investigated within metabolic research.
The GLP-1 receptor represents another important incretin pathway studied extensively in molecular and metabolic research.
Tirzepatide combines agonist activity at both receptors within a single molecule. This provides researchers with a useful model for examining dual-receptor signalling and comparing it with compounds that primarily target a single receptor pathway.

99%+ Purity & Batch Traceability

Tirzepatide 60mg is specified at 99%+ purity for laboratory research applications. Purity and material identity are important considerations when designing experiments where consistency and traceability are required.
Where available, researchers should review the Certificate of Analysis (COA) corresponding to the specific production batch. Analytical documentation may provide information concerning identity, purity and testing associated with the supplied material.
Batch numbers and supporting documentation should be retained alongside laboratory records.